Table 3. Odds ratios (ORs) with 95% confidence intervals and p-values predicting the probability of “success” at 6 months after discontinuation of active treatment.
| OR (95% CI) | p-value | |
|---|---|---|
| Demographic characteristics | ||
| Age (per 10 years) | 0.85 (0.7, 1.04) | 0.12 |
| Ethnicity | 0.95 | |
| Non-Hispanic Whites | Reference | |
| Non-Hispanic Blacks | 1.06 (0.5, 2.25) | |
| Hispanic | 0.74 (0.26, 2.1) | |
| Other | 0.95 (0.32, 2.8) | |
| Education | 0.83 | |
| 0:<=HS/GED | Reference | |
| 1:>HS | 1.07 (0.56, 2.06) | |
| Household Income | 0.74 | |
| 1: <$20,000 | Reference | |
| 2: $20,000-$49,999 | 1.1 (0.52, 2.33) | |
| 3: $50,000-$79,999 | 0.71 (0.29, 1.77) | |
| 4: >=$80,000 | 1.17 (0.48, 2.87) | |
| Occupational Score (per 10 units) | 1.01 (0.9, 1.14) | 0.84 |
| Baseline Incontinence Characteristics | ||
| Mesa Urge Score | 1.02 (0.94, 1.11) | 0.56 |
| Mesa Stress Score | 1.01 (0.97, 1.06) | 0.61 |
| Number of Incontinence Episodes on Bladder Diary | 0.98 (0.87, 1.1) | 0.72 |
| IIQ scores (per 10 units) | 0.997 (0.97, 1.03) | 0.85 |
| OAB-q score | 1.002 (0.99, 1.01) | 0.77 |
| Duration of Incontinence | 0.999 (0.97, 1.03) | 0.92 |
| Prior Treatment/Surgery for Incontinence (%) | 0.16 | |
| Yes | 0.66 (0.37, 1.17) | |
| No | Reference | |
| Medical History and Physical | ||
| Self assessment of Overall Health | 0.08 | |
| 1: Excellent | 0.49 (0.14, 1.63) | |
| 2: Very Good | 1.74 (0.78, 3.92) | |
| 3: Good | 0.96 (0.42, 2.23) | |
| 4: Fair/poor | Reference | |
| Fluid Intake | 0.99 (0.98, 1) | 0.17 |
| Current Estrogen Use | 0.13 | |
| 1: Post-menopausal on HRT | 1.53 (0.68, 3.46) | |
| 2: Post-menopausal not on HRT | 0.7 (0.37, 1.32) | |
| 3: Pre-menopausal | Reference | |
| Diabetes (%) | 0.33 | |
| Yes | 0.63 (0.25, 1.59) | |
| No | Reference | |
| Body Mass Index | 0.99 (0.96, 1.02) | 0.51 |
| POP-Q scores (Stage) | 0.57 | |
| Stage 0/I | 3.24 (0.36, 28.87) | |
| Stage II | 3.23 (0.36, 29.36) | |
| Stage III/IV | Reference | |
| POPQ _AA | 1.33 (1.03, 1.7) | 0.03 |
| POPQ BA | 1.25 (0.99, 1.59) | 0.06 |
| POPQ_Bp | 0.95 (0.73, 1.24) | 0.73 |
| POPQ C | 0.98 (0.88, 1.08) | 0.64 |
| Pelvic floor muscle strength (Brinks) | 0.97 (0.82, 1.15) | 0.73 |
| Fecal Incontinence | ||
| Yes | 0.79 (0.39, 1.59) | 0.50 |
| No | Reference | |
| SF-12 | ||
| PCS12 | 1.02 (0.99, 1.04) | 0.18 |
| MCS12 | 0.99 (0.96, 1.02) | 0.48 |
| HUI2 Overall | 2.9 (0.4, 21.24) | 0.30 |
Note: * P-values, OR's and 95% CI's are from logistic regression models including each covariate separately controlling for treatment group and treatment outcome at 10 week